gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
CMV peptide–HLA engagement of the native TCR is used to boost expansion/persistence; killing is triggered by the anti-CD19 CAR against CD19+ cells via perforin/granzyme-mediated cytotoxicity.
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
peptide–HLA complex recognized by native CMV-specific TCR
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05801913
disease_id_num_tar_ref
6066
drug_id_num_tar_ref
16438